Literature DB >> 21559840

Unloading the infarcted heart affect MMPs-TIMPs axis in a rat cardiac heterotopic transplantation model.

Wei-jian Wang1, Zi-li Meng, Yun-chang Mo, Jun-wei Liu, Cheng-chao Sun, Sheng-shou Hu, Hao Zhang.   

Abstract

Ventricular assist devices may function as a bridge to recovery or heart transplantation, however, little is known about its mechanisms. This study examined the role of matrix metalloproteinases (MMP)-tissue inhibitors of metalloproteinases (TIMP) axis in the process of recovery after unloading in a rat ischemic-induce heart failure (HF) model. Myocardial infarction model was created with the coronary artery ligation. The infarcted rats hearts were unloaded by heterotopic cardiac transplantation (n=14). 2 weeks later, the function of normal and infarcted hearts with or without loading was evaluated by Langendorff perfusion model. The hearts were then harvested and prepared for the study of expression of MMPs and TIMPs. Developed pressure in the unloading group was higher than the loading group (P=0.0074). Unloading increased the ratio of TIMP-1-MMP-1(1.38±0.11 vs. 0.76±0.09, P<0.05), TIMP-2-MMP-2 (1.06±0.10 vs. 0.33±0.07, P<0.01), TIMP-3-MMP-9(1.07±0.08 vs. 0.59±0.06, P<0.05). Although MMP-1, 2, 9 were downregulated (P<0.01, 0.01, 0.05, respectively), TIMP-2 and TIMP-3 upregulated (P<0.01, 0.05, respectively), MMP-7 and TIMP-1 was not affected significantly. The infarcted cardiac function could be improved by unloading. It was attributed to downregulation of MMP-1, 2 and 9, and upregulation of TIMP-2 and -3, and furthermore, the ratio of TIMPs to MMPs was increased, which might be more sensitive than sole MMPs or TIMPs for the judgment of myocardial matrix homeostasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21559840     DOI: 10.1007/s11033-011-0736-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  29 in total

1.  Effect of matrix metalloproteinase inhibition by doxycycline on myocardial healing and remodeling after myocardial infarction.

Authors:  Ariel Tessone; Micah S Feinberg; Israel M Barbash; Reuven Reich; Radka Holbova; Michal Richmann; Yael Mardor; Jonathan Leor
Journal:  Cardiovasc Drugs Ther       Date:  2005-12       Impact factor: 3.727

2.  Reloading the heart: a new animal model of left ventricular assist device removal.

Authors:  Tomohiro Mizuno; Richard D Weisel; Ren-Ke Li
Journal:  J Thorac Cardiovasc Surg       Date:  2005-07       Impact factor: 5.209

3.  Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.

Authors:  J T Peterson; H Li; L Dillon; J W Bryant
Journal:  Cardiovasc Res       Date:  2000-05       Impact factor: 10.787

4.  Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.

Authors:  C V Thomas; M L Coker; J L Zellner; J R Handy; A J Crumbley; F G Spinale
Journal:  Circulation       Date:  1998-05-05       Impact factor: 29.690

5.  Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit.

Authors:  A M Romanic; C L Burns-Kurtis; B Gout; I Berrebi-Bertrand; E H Ohlstein
Journal:  Life Sci       Date:  2001-01-05       Impact factor: 5.037

6.  Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy.

Authors:  Hao Zhang; Shafie Fazel; Hai Tian; Donald A G Mickle; Richard D Weisel; Takeshiro Fujii; Ren-Ke Li
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-11       Impact factor: 4.733

7.  Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats.

Authors:  Mai Hou; Ke-ming Yang; Hao Zhang; Wei-Quan Zhu; Fu-jian Duan; Hao Wang; Yun-hu Song; Ying-jie Wei; Sheng-shou Hu
Journal:  Int J Cardiol       Date:  2006-08-04       Impact factor: 4.164

8.  Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction.

Authors:  Daniel R Wagner; Charles Delagardelle; Isabelle Ernens; Didier Rouy; Michel Vaillant; Jean Beissel
Journal:  J Card Fail       Date:  2006-02       Impact factor: 5.712

Review 9.  Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.

Authors:  Francis G Spinale
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

10.  Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.

Authors:  Prasanna Krishnamurthy; J Thomas Peterson; Venkateswaran Subramanian; Mahipal Singh; Krishna Singh
Journal:  Mol Cell Biochem       Date:  2008-11-01       Impact factor: 3.396

View more
  4 in total

1.  Parthenolide inhibits the proliferation and induces the apoptosis of human uveal melanoma cells.

Authors:  Song-Tian Che; Li Bie; Xu Li; Hui Qi; Peng Yu; Ling Zuo
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

2.  Inhibition of human glioma U251 cells growth in vitro and in vivo by hydroxyapatite nanoparticle-assisted delivery of short hairpin RNAs against SATB1.

Authors:  Sheng-Hua Chu; Zhang-Ming Zhou; Dong-Fu Feng; Yan-Bin Ma
Journal:  Mol Biol Rep       Date:  2013-12-27       Impact factor: 2.316

Review 3.  Rat Heterotopic Heart Transplantation Model to Investigate Unloading-Induced Myocardial Remodeling.

Authors:  Xuebin Fu; Adrian Segiser; Thierry P Carrel; Hendrik T Tevaearai Stahel; Henriette Most
Journal:  Front Cardiovasc Med       Date:  2016-10-19

4.  A New Animal Model for Investigation of Mechanical Unloading in Hypertrophic and Failing Hearts: Combination of Transverse Aortic Constriction and Heterotopic Heart Transplantation.

Authors:  Andreas Schaefer; Yvonne Schneeberger; Justus Stenzig; Daniel Biermann; Marisa Jelinek; Hermann Reichenspurner; Thomas Eschenhagen; Heimo Ehmke; Alexander P Schwoerer
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.